Kenai Therapeutics, a biotechnology company leveraging induced pluripotent stem cell (iPSC) technology to discover and develop a platform of off-the-s ...

In December 2024, we received approval to initiate our Phase 1b clinical trial of GT-02287 in people with GBA1 or idiopathic Parkinson’s disease. This followed the completion of our study in healthy ...

Gain Therapeutics, Inc. (Nasdaq: GANX) ("Gain", or the "Company"), a clinical-stage biotechnology company leading the discovery and development of the ...

Gain Therapeutics (GANX) provided a letter to shareholders from the Company’s President and CEO, Gene Mack, which read in part,”With 2025 ...

In December 2024, we received approval to initiate our Phase 1b clinical trial of GT-02287 in people with GBA1 or idiopathic Parkinson's disease. This followed the completion of our study in healthy ...

Researchers examined 72 participants with a condition known as idiopathic Rapid Eye Movement Behavior Disorder (iRBD), a behavioral disorder that has been linked to Parkinson’s disease.

A Colorado Springs family hopes to win what they believe would be a landmark legal verdict by proving to jurors next month that mold exposure in a rented apartment caused Parkinson's disease in a ...

After being diagnosed with Parkinsonism, Steuart Smith is retiring as lead guitarist for the Eagles. The 72-year-old musician, who has acted as the “Hotel California” band’s co-lead guitarist for ...

Kevin Hill said he is able to go for days now without thinking about his Parkinson's A man fitted with a pioneering, computer-controlled brain implant to tackle his Parkinson's disease says it ...

A man fitted with a pioneering, computer-controlled brain implant to tackle his Parkinson's disease says it works so well he is sometimes able to forget he has the condition. A small computer ...